Mark B Feinberg

Title: The Innovative Contributions of Mark B Feinberg

Introduction

Mark B Feinberg is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biomedical research, particularly in the development of viral vaccines. With a total of 3 patents, his work has had a profound impact on vaccine technology and infectious disease prevention.

Latest Patents

Feinberg's latest patents include groundbreaking inventions such as replication-competent recombinant viral vaccines and methods for producing them. This technology involves replication-competent recombinant viruses, specifically polioviruses, which incorporate exogenous nucleic acid sequences. These sequences encode an exogenous polypeptide and an artificial proteolytic cleavage site, allowing for the production of various proteins essential for vaccine efficacy. His work on non-infectious HIV particles is also noteworthy. This invention focuses on constructs with mutant HIV genomes that alter nucleotide sequences critical for genomic RNA packaging. The resulting non-infectious, immunogenic HIV particles can be produced in mammalian cell lines, paving the way for new prophylactic and therapeutic vaccines.

Career Highlights

Throughout his career, Feinberg has worked with esteemed organizations such as the Whitehead Institute for Biomedical Research and American Cyanamid Company. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in the field of virology.

Collaborations

Feinberg has collaborated with notable scientists, including Anna Aldovini and Richard A Young. These partnerships have further enriched his research and expanded the impact of his inventions.

Conclusion

Mark B Feinberg's contributions to the field of biomedical research and vaccine development are invaluable. His innovative patents and collaborations highlight his commitment to advancing medical science and improving public health.